bioRxivBiochemistryPreprint
Binding Of A Newly Identified Essential Light Chain To Expressed Plasmodium falciparum Class XIV Myosin Enhances Actin Motility
Carol S. Bookwalter, Chwen L. Tay, Rama McCrorie, Michael J. PrevisiD, Elena B. Krementsova, Patricia M. FagnantiD, Jake BaumiD, Kathleen M. TrybusiD
Abstract
Motility of the apicomplexan parasite Plasmodium falciparum, the causative agent of malaria, is enabled by the glideosome, a multi-protein complex containing the class XIV myosin motor, PfMyoA. Parasite motility is necessary for invasion into host cells and for virulence. Here we show that milligram quantities of functional PfMyoA can be expressed using the baculovirus/Sf9 cell expression system, provided that a UCS (UNC-45/CRO1/She4p) family myosin co-chaperone from Plasmodium spp. is co-expressed with the heavy chain. The homologous chaperone from the apicomplexan Toxoplasma gondii does not functionally substitute. We expressed a functional full-length PfMyoA with bound myosin tail interacting protein (MTIP), the only known light chain of PfMyoA. We then identified an additional \"essential\" light chain (PfELC) that co-purified with PfMyoA isolated from parasite lysates. PfMyoA expressed with both light chains moved actin at ~3.8 m/sec, more than twice that of PfMyoA-MTIP (~1.7 m/sec), consistent with the light chain binding domain acting as a lever arm to amplify nucleotide-dependent motions in the motor domain. Surprisingly, PfMyoA moved skeletal actin or expressed P. falciparum actin at the same speed. Duty ratio estimates suggest that PfMyoA may be able to move actin at maximal speed with as few as 6 motors. Under unloaded conditions, neither phosphorylation of Ser19 of the heavy chain, phosphorylation of several Ser residues in the N-terminal extension of MTIP, or calcium affected the speed of actin motion. These studies provide the essential framework for targeting the glideosome as a potential drug target to inhibit invasion by the malaria parasite.\n\nSignificanceMotility of the apicomplexan parasite Plasmodium falciparum, the causative agent of malaria, relies on a divergent actomyosin system powered by the class XIV myosin, PfMyoA. We show that functional PfMyoA can be expressed in Sf9 cells if a Plasmodium spp. myosin chaperone is co-expressed. We identified an \"essential\" light chain (PfELC) that binds to PfMyoA in parasites. In vitro expression of PfMyoA heavy chain with PfELC and the known light chain MTIP produced the fastest speeds of actin movement (~3.8 m/sec). Duty ratio estimates suggest that ~6 PfMyoA motors can move actin at maximal speed, a feature that may facilitate interaction with short, dynamic Plasmodium actin filaments. Our findings enable drug screening for myosin-based inhibitors of Plasmodium cellular invasion.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Structure of Full Length Plasmodium Myosin A and its light chain PfELC, dual targets against malaria parasite pathogenesis
D. Moussaoui, J. P. Robblee, … A. Houdusse·bioRxiv·Jun 30, 2020
- Plasmodium falciparum Myosin B is a slow motor optimized for force generation
James P. Robblee, Dihia Moussaoui, … Julien Robert‐Paganin·bioRxiv·Sep 12, 2026
- Dynamic phosphorylation of the Plasmodium falciparum Myosin A motor regulates motor speed and is important for asexual replication
Stephanie D. Nofal, Konstantinos Koussis, … David A. Baker·bioRxiv·Sep 18, 2026
- Characterization of Plasmodium falciparum myosin B in complex with the calmodulin-like domain of its light chain MLC-B
I. Pires, Y.-F. Hung, … I. Kursula·bioRxiv·May 28, 2022
- High-resolution structures of malaria parasite actomyosin and actin filaments
J. Vahokoski, L. J. Calder, … I. Kursula·bioRxiv·Jul 2, 2020
- Systematic analysis of Plasmodium myosins reveals differential expression, localization and function in invasive and proliferative parasite stages
R. J. Wall, M. ZEESHAN, … R. Tewari·bioRxiv·Jun 14, 2019